Shrimp Disease Diagnostics Market by Kit (Assay Based Kit, Rapid Testing Kit), Disease (Early Mortality Syndrome, Taura Syndrome Virus, White Spot Syndrome Virus), End User - Global Forecast 2024-2030

Shrimp Disease Diagnostics Market by Kit (Assay Based Kit, Rapid Testing Kit), Disease (Early Mortality Syndrome, Taura Syndrome Virus, White Spot Syndrome Virus), End User - Global Forecast 2024-2030


The Shrimp Disease Diagnostics Market size was estimated at USD 443.18 million in 2023 and expected to reach USD 478.10 million in 2024, at a CAGR 7.92% to reach USD 755.83 million by 2030.

Shrimp disease refers to various infectious and non-infectious conditions that affect the health, growth, and survival of shrimp in aquaculture systems. These diseases can be caused by various pathogens, such as bacteria, viruses, parasites, and fungi. The shrimp disease diagnostics technologies encompass various diagnostics tools such as morphological pathology (direct light microscopy, histopathology, electron microscopy), enhancement and bioassay methods, traditional microbiology, nucleic acid-based PCR assays, and serological methods to detect the prevalence of disease among shrimp population. The growing global demand for seafood products due to consumer preference for healthier protein sources and rising incidences of abiotic and biotic stresses and chronic diseases among the shrimp population has necessitated the deployment of shrimp disease diagnostics tools. However, the high cost of advanced diagnostic technologies may hinder the adoption of diagnostic tools among small-scale farms or developing countries. Furthermore, the lack of skilled personnel to perform complex diagnostic procedures and the absence of standardized testing protocols for shrimp disease prediction pose hurdles for the adoption of shrimp disease diagnostics strategies. To address these challenges and capitalize on existing opportunities, businesses operating within the shrimp disease diagnostics market should focus on innovation, research-driven product development, and collaboration with stakeholders across the industry. Furthermore, advancements in diagnostic technology and the utilization of nanotechnology for disease diagnosis can propel the growth and adoption of shrimp disease diagnostics.

Regional Insights

In the Americas, particularly Latin America and the Caribbean region, shrimp aquaculture is a major source of income for many coastal communities. The United States also has considerable coastal areas focused on aquaculture and shrimp production. In recent years, there has been an increased focus on implementing biosecurity measures to prevent the spread of diseases such as white spot syndrome virus (WSSV) and early mortality syndrome (EMS). There are some regional companies actively involved in research or product development related to shrimp disease diagnostics, and they offer molecular diagnostic services focused on early identification and management of pathogens affecting shrimps. Asia accounts for a large proportion of global shrimp production among China, India, Thailand, Vietnam, and Indonesia and requires proper diagnostics for this region's growing aquaculture sector. The company scenario in the Asian market is characterized by both international players providing a variety of diagnostic assays and instruments, as well as regional companies that focus on developing innovative solutions tailored to local needs. In Europe, countries, including Spain and France, emphasize biosecurity measures and strict monitoring protocols to prevent the introduction of diseases such as WSSV into their domestic farming operations. European countries contribute significantly to the development and production of advanced diagnostic tools for shrimp diseases. Some European institutions engage in research collaborations with aquaculture stakeholders from other regions to help improve diagnostics capabilities globally.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Shrimp Disease Diagnostics Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers
  • Growing shrimp production and export activities worldwide
  • Public-private awareness initiatives and welfare projects to tackle shrimp diseases
  • Regulations for quality shrimp farming and need for efficient disease detection tools
Market Restraints
  • Complex testing procedures and need for trained personnel
Market Opportunities
  • Advancements in shrimp diagnostics technologies and rapid testing methods
  • New investments in expansion of shrimp farming activities
Market Challenges
  • Limitations associated with false positives and inaccuracy of shrimp disease diagnostics
Market Segmentation Analysis
  • Kit: Growing adoption of rapid testing kits for quick and easy detection of pathogens
  • Disease: Highly contagious nature of white spot syndrome virus (WSSV) necessitating quality PCR and histological tests
  • End User: Rising incidences of shrimp disease outbreaks in fisheries necessitating deployment of shrimp disease diagnostics strategies
Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Shrimp Disease Diagnostics Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Shrimp Disease Diagnostics Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

US Project to Develop Low-Cost White Spot Test for Shrimp Farmers

The US Department of Agriculture (USDA) is investing more than USD 12.5 million into the USDA Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs into Gloucester Marine Genomics Institute (GMGI) and Sherlock Biosciences. Both companies are designing CRISPR based diagnostic tools to quickly detect viruses and other pathogens, eliminating the need for laboratory or expensive equipment.

ViAqua Therapeutics Secures Funding for RNA-based Aquaculture Disease Management

ViAqua Therapeutics, a biotechnology company, has secured USD 8.25 million in funding to advance the development of their orally administered RNA-particle platform. This innovative technology aims to promote and enhance animal health in aquaculture such as Shrimp that are highly susceptible to diseases.

Aquatreck Signs Research Agreement to Develop Diagnostic Services for Fish Farms

Aquatreck Animal Health, a Spanish fish vaccine company, has entered into an exclusive research agreement with Biodetect, a diagnostic lab at the University of Patras. The agreement aims to develop a range of innovative diagnostic services for the aquaculture sector, with the goal of enhancing farm vaccination plans and establishing an early warning system for identifying emerging pathogens in the farm environment.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Shrimp Disease Diagnostics Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Shrimp Disease Diagnostics Market, highlighting leading vendors and their innovative profiles. These include 3 Little Fish Sdn Bhd, Amazing Biotech, Aquaintech Inc., Arachem (M) Sdn Bhd, Bioneer Corporation, Blue Aqua International Pte. Ltd., CD Genomics, China Guangzhou BioKey Healthy Technology Co. Ltd, DSM Austria GmbH, Forte Biotech, GeneReach Biotechnology Corp., GeneReach Biotechnology Corporation, Genics Pty. Ltd., Illumina, Inc., Innocreate Bioscience Co., Ltd., Lab-Ind Resource Sdn. Bhd., Laboratory Corporation of America Holdings, Mahesh Aqua Holdings (Pvt) Ltd., Mylab Discovery Solutions Pvt. Ltd., PT Riset Nusantara Genetika (Nusantics), Randox Laboratories Ltd., Reagen LLC, Ring Biotechnology Co Ltd., Speedy Assay Sdn. Bhd., SUREBIO, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Shrimp Disease Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Kit
  • Assay Based Kit
  • Rapid Testing Kit
  • Disease
  • Early Mortality Syndrome
  • Taura Syndrome Virus
  • White Spot Syndrome Virus
  • Yellow Head or Gill Associated Virus
  • End User
  • Aquaculture & Marine Laboratories
  • Education & Research Institutes
  • Fisheries
  • Region
    • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
    • California
    • Florida
    • Illinois
    • New York
    • Ohio
    • Pennsylvania
    • Texas
    • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
    • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom


    Please Note: PDF & Excel + Online Access - 1 Year


    1. Preface
    1.1. Objectives of the Study
    1.2. Market Segmentation & Coverage
    1.3. Years Considered for the Study
    1.4. Currency & Pricing
    1.5. Language
    1.6. Stakeholders
    2. Research Methodology
    2.1. Define: Research Objective
    2.2. Determine: Research Design
    2.3. Prepare: Research Instrument
    2.4. Collect: Data Source
    2.5. Analyze: Data Interpretation
    2.6. Formulate: Data Verification
    2.7. Publish: Research Report
    2.8. Repeat: Report Update
    3. Executive Summary
    4. Market Overview
    5. Market Insights
    5.1. Market Dynamics
    5.1.1. Drivers
    5.1.1.1. Growing shrimp production and export activities worldwide
    5.1.1.2. Public-private awareness initiatives and welfare projects to tackle shrimp diseases
    5.1.1.3. Regulations for quality shrimp farming and need for efficient disease detection tools
    5.1.2. Restraints
    5.1.2.1. Complex testing procedures and need for trained personnel
    5.1.3. Opportunities
    5.1.3.1. Advancements in shrimp diagnostics technologies and rapid testing methods
    5.1.3.2. New investments in expansion of shrimp farming activities
    5.1.4. Challenges
    5.1.4.1. Limitations associated with false positives and inaccuracy of shrimp disease diagnostics
    5.2. Market Segmentation Analysis
    5.2.1. Kit: Growing adoption of rapid testing kits for quick and easy detection of pathogens
    5.2.2. Disease: Highly contagious nature of white spot syndrome virus (WSSV) necessitating quality PCR and histological tests
    5.2.3. End User: Rising incidences of shrimp disease outbreaks in fisheries necessitating deployment of shrimp disease diagnostics strategies
    5.3. Market Disruption Analysis
    5.4. Porter’s Five Forces Analysis
    5.4.1. Threat of New Entrants
    5.4.2. Threat of Substitutes
    5.4.3. Bargaining Power of Customers
    5.4.4. Bargaining Power of Suppliers
    5.4.5. Industry Rivalry
    5.5. Value Chain & Critical Path Analysis
    5.6. Pricing Analysis
    5.7. Technology Analysis
    5.8. Patent Analysis
    5.9. Trade Analysis
    5.10. Regulatory Framework Analysis
    6. Shrimp Disease Diagnostics Market, by Kit
    6.1. Introduction
    6.2. Assay Based Kit
    6.3. Rapid Testing Kit
    7. Shrimp Disease Diagnostics Market, by Disease
    7.1. Introduction
    7.2. Early Mortality Syndrome
    7.3. Taura Syndrome Virus
    7.4. White Spot Syndrome Virus
    7.5. Yellow Head or Gill Associated Virus
    8. Shrimp Disease Diagnostics Market, by End User
    8.1. Introduction
    8.2. Aquaculture & Marine Laboratories
    8.3. Education & Research Institutes
    8.4. Fisheries
    9. Americas Shrimp Disease Diagnostics Market
    9.1. Introduction
    9.2. Argentina
    9.3. Brazil
    9.4. Canada
    9.5. Mexico
    9.6. United States
    10. Asia-Pacific Shrimp Disease Diagnostics Market
    10.1. Introduction
    10.2. Australia
    10.3. China
    10.4. India
    10.5. Indonesia
    10.6. Japan
    10.7. Malaysia
    10.8. Philippines
    10.9. Singapore
    10.10. South Korea
    10.11. Taiwan
    10.12. Thailand
    10.13. Vietnam
    11. Europe, Middle East & Africa Shrimp Disease Diagnostics Market
    11.1. Introduction
    11.2. Denmark
    11.3. Egypt
    11.4. Finland
    11.5. France
    11.6. Germany
    11.7. Israel
    11.8. Italy
    11.9. Netherlands
    11.10. Nigeria
    11.11. Norway
    11.12. Poland
    11.13. Qatar
    11.14. Russia
    11.15. Saudi Arabia
    11.16. South Africa
    11.17. Spain
    11.18. Sweden
    11.19. Switzerland
    11.20. Turkey
    11.21. United Arab Emirates
    11.22. United Kingdom
    12. Competitive Landscape
    12.1. Market Share Analysis, 2023
    12.2. FPNV Positioning Matrix, 2023
    12.3. Competitive Scenario Analysis
    12.3.1. US Project to Develop Low-Cost White Spot Test for Shrimp Farmers
    12.3.2. ViAqua Therapeutics Secures Funding for RNA-based Aquaculture Disease Management
    12.3.3. Aquatreck Signs Research Agreement to Develop Diagnostic Services for Fish Farms
    12.4. Strategy Analysis & Recommendation
    13. Competitive Portfolio
    13.1. Key Company Profiles
    13.2. Key Product Portfolio

    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook
    Cookie Settings